Balentine LLC Elevance Health, Inc. Transaction History

Balentine LLC

$2.23 Billion
Q1 2025

A detailed history of Balentine LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Balentine LLC holds 542 shares of ELV stock, worth $218,583. This represents 0.01% of its overall portfolio holdings.

Number of Shares

542

Previous 577 6.07%

Holding current value

$218,583

Previous $213,000 10.33%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	SELL	$365.9 - $436.25 $12,806 - $15,268	-35 Reduced 6.07%	542 $235,000
Q4 2024 Jan 29, 2025	SELL	$365.96 - $514.62 $551,135 - $775,017	-1,506 Reduced 72.3%	577 $213,000
Q3 2024 Oct 30, 2024	BUY	$500.12 - $562.29 $753,180 - $846,808	1,506 Added 261.01%	2,083 $1.08 Million
Q2 2024 Aug 07, 2024	SELL	$497.49 - $547.8 $660,666 - $727,478	-1,328 Reduced 69.71%	577 $312,000
Q1 2024 May 15, 2024	SELL	$464.61 - $519.96 $19,978 - $22,358	-43 Reduced 2.21%	1,905 $987,000
Q4 2023 Feb 09, 2024	SELL	$433.51 - $488.06 $167,334 - $188,391	-386 Reduced 16.54%	1,948 $918,000
Q3 2023 Nov 13, 2023	BUY	$414.13 - $475.93 $65,432 - $75,196	158 Added 7.26%	2,334 $1.02 Million
Q2 2023 Aug 14, 2023	SELL	$436.33 - $496.2 $190,239 - $216,343	-436 Reduced 16.69%	2,176 $966,000
Q1 2023 May 11, 2023	SELL	$446.3 - $502.2 $524,848 - $590,587	-1,176 Reduced 31.05%	2,612 $1.2 Million
Q4 2022 Jan 31, 2023	SELL	$465.23 - $546.77 $118,168 - $138,879	-254 Reduced 6.28%	3,788 $1.94 Million
Q3 2022 Oct 26, 2022	SELL	$445.98 - $507.0 $2.27 Million - $2.58 Million	-5,097 Reduced 55.77%	4,042 $1.84 Million
Q2 2022 Oct 26, 2022	BUY	$444.32 - $529.84 $2.09 Million - $2.49 Million	4,696 Added 105.69%	9,139 $4.41 Million
Q2 2022 Aug 15, 2022	BUY	$444.32 - $529.84 $4.06 Million - $4.84 Million	9,139 New	9,139 $4.41 Million
Q1 2022 Oct 26, 2022	SELL	$428.44 - $502.48 $2.01 Million - $2.36 Million	-4,696 Reduced 51.38%	4,443 $2.18 Million
Q4 2021 Oct 26, 2022	SELL	$370.08 - $467.67 $2.87 Million - $3.63 Million	-7,754 Reduced 84.85%	1,385 $642,000
Q4 2021 Feb 02, 2022	SELL	$370.08 - $467.67 $391,544 - $494,794	-1,058 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$357.51 - $398.13 $176,967 - $197,074	495 Added 87.92%	1,058 $395,000
Q2 2021 Aug 16, 2021	BUY	$352.19 - $401.9 $198,282 - $226,269	563 New	563 $215,000
Q3 2020 Nov 02, 2020	SELL	$245.73 - $284.63 $29,979 - $34,724	-122 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$203.3 - $300.59 $91,485 - $135,265	-450 Reduced 78.67%	122 $32,000
Q1 2020 May 18, 2020	BUY	$174.68 - $307.74 $60,613 - $106,785	347 Added 154.22%	572 $130,000
Q4 2019 Sep 02, 2020	BUY	$234.82 - $306.42 $40,623 - $53,010	173 Added 332.69%	225 $68,000
Q3 2019 Nov 15, 2019	BUY	$237.69 - $310.48 $4,753 - $6,209	20 Added 62.5%	52 $12,000
Q2 2019 Aug 14, 2019	BUY	$236.25 - $293.76 $7,560 - $9,400	32 New	32 $9,000

Others Institutions Holding ELV

# of Institutions

1,884

Shares Held

203M

Call Options Held

1.67M

Put Options Held

1.15M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $96.8B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account